Terms and Conditions
Copyright ©2008 Cephalon, Inc. All rights reserved. BEFORE ACCESSING THIS SITE,
PLEASE READ THE FOLLOWING TERMS AND CONDITIONS CAREFULLY AS THEY GOVERN YOUR USE
OF THIS SITE. IF YOU DO NOT AGREE WITH THESE TERMS AND CONDITIONS, YOU ARE NOT GRANTED
PERMISSION BY CEPHALON, INC., TO ACCESS OR OTHERWISE USE THIS SITE.
THEWAKEUPSQUAD.COM User Agreement
Welcome to the Wake-Up Squad Web site (also referred to as the "Site") owned and
operated by Cephalon, Inc ("Cephalon"). This Agreement contains the terms, covenants,
conditions, and provisions (the "Terms and Conditions") upon which you ("You") may
access and use this Site.
Terms and Conditions
By accessing, viewing, or using this Site, You, the User, indicate that you understand
and intend these Terms and Conditions to be the legal equivalent of a signed, written
contract and equally binding, and that you accept such Terms and Conditions and
agree to be legally bound by them. Please note that Cephalon reserves the right
to change these Terms and Conditions. Your continued use of this Site following
such modifications will be conclusively deemed acceptance of any changes to these
Terms and Conditions.
License Grant
This Agreement provides You with a personal, revocable, nonexclusive, nontransferable
license to use this Site conditioned on Your continued compliance with the Terms
and Conditions of this Agreement. You may print and download materials and information
on this Site solely for personal and noncommercial use, provided that all hard copies
contain all copyright and other applicable notices contained in such materials and
information. As a further condition of use of this Site, You warrant to Cephalon
that You will not use this Site for any purpose that is unlawful or otherwise prohibited
by these Terms and Conditions.
Intellectual Property Rights
All materials contained in the Site are protected by law, including but not limited
to US copyright, trade secret, and trademark law, as well as other state, national,
and international laws and regulations. The contents of and all materials distributed
in conjunction with the Site are Copyright ©2008 Cephalon, Inc., or its licensors
or suppliers. All rights reserved. Cephalon also owns a copyright in the Site as
a collective work and/or compilation, and in the selection, coordination, arrangement,
and enhancement of such content. Republication or citation of any other content
generated by the Site without Cephalon's written consent is expressly prohibited.
You agree not to copy, modify, adapt, frame, mirror, reproduce, translate, distribute,
transmit, reverse engineer, decompile, or disassemble any aspect of the Site, except
as expressly allowed by this Agreement. All product names, whether or not appearing
in large print, italics or with the trademark symbol, are trademarks of Cephalon,
Inc., its affiliates, related companies or its licensors or joint venture partners
and any use of such marks without the express written permission of Cephalon is
strictly prohibited. Unauthorized use of any material contained on this Site may
violate copyright laws, trademark laws, trade secret laws, the laws of privacy and
publicity, and communications regulations and statutes. Please be aware that Cephalon
actively and aggressively enforces its intellectual property rights to the fullest
extent of the law.
Copyright Owners' Rights Under the Digital Millennium Copyright Act of 1998
The Digital Millennium Copyright Act of 1998 (the "DMCA") provides recourse for
copyright owners who believe that material appearing on the Internet infringes their
rights under US copyright law. If You believe in good faith that materials hosted
by Cephalon infringe your copyright, You (or your agent) may send us a notice requesting
that the materials be removed, or access to them blocked. If You believe in good
faith that a notice of copyright infringement has been wrongly filed against You,
the DMCA permits You to send us a counter-notice.
Notices and counter-notices must meet statutory requirements imposed by the DMCA.
One place to find more information on the DMCA is the US Copyright Office Web site.
Notices and counter-notices for the Site should be sent to Robert T. Hrubiec, Ph.D.,
J.D., Intellectual Property, Cephalon Inc., 145 Brandywine Parkway, West Chester,
PA 19380.
Submissions
Cephalon welcomes your feedback and suggestions about how to improve this Site.
Any ideas, suggestions, information, know-how, material, or other content (collectively,
"Content") received through this Site, however, will be deemed to include a royalty-free,
perpetual, irrevocable, transferable, worldwide, nonexclusive right and license
for Cephalon to adopt, publish, reproduce, disseminate, transmit, distribute, copy,
use, create derivative works, display (in whole or part), or act on such Content
without additional approval or consideration, in any form, media, or technology
now known or later developed for the full term of any rights that may exist in such
Content.
Jurisdiction
The information provided on this Site is intended for US audiences and has been
designed to comply with US regulatory guidelines.
Disclaimer
Medical information that appears on this Web site is for informational purposes
only and is not, nor is intended to be, a medical diagnosis or a replacement for
advice given by a physician or other medical professional. Any reliance on the information
provided on this Web site is solely the responsibility of the individual. While
Cephalon, Inc., makes reasonable efforts to ensure the timeliness and accuracy of
the materials present on this Web site, it makes no assurances or warranties (express
or implied) as to the accuracy of the information provided on this Web site and
shall not be liable for any direct, indirect, incidental, consequential or otherwise
special damages or injuries resulting from the use of this Web site and reliance
on the materials contained here. Cephalon, Inc., may make changes to these materials
at any time, without notice, and makes no commitment to update the information contained
herein.
This Web site may link you to other Web sites that are not owned or controlled by
Cephalon, Inc. Links are provided for your convenience only. These sites are maintained
by entities over which Cephalon, Inc., exercises no control. Accordingly, Cephalon,
Inc., expressly disclaims any responsibility for the content, the accuracy of the
information and/or quality of products or services provided by or advertised on
these third-party sites. If you choose to hyperlink to another Web site, you do
so at your own risk.
Forward Looking Statement
This Web site contains "forward looking statements" in addition to historical facts
or statements of current conditions. Forward looking statements provide Cephalon,
Inc.'s current expectations or forecasts of future events. These may include statements
regarding anticipated scientific progress on its research programs, development
of potential pharmaceutical products, interpretation of clinical results, prospects
for regulatory approval, manufacturing development and capabilities, market prospects
for its products, sales and earnings projections, and other statements regarding
matters that are not historical facts. You may identify some of these forward looking
statements by the use of words in the statements such as "anticipate," "estimate,"
"expect," "project," "intend," "plan," "believe," or other words and terms of similar
meaning. Cephalon, Inc.'s performance and financial results could differ materially
from those reflected in these forward-looking statements due to general financial,
economic, regulatory, and political conditions affecting the biotechnology and pharmaceutical
industries as well as more specific risks and uncertainties such as those set forth
below and in its reports on Form 8-K, 10-Q and 10-K filed with the US Securities
and Exchange Commission. Given these risks and uncertainties, any or all of these
forward looking statements may prove to be incorrect. Therefore, you should not
rely on any such factors or forward looking statements. Furthermore, Cephalon, Inc.,
is not obligated and does not intend to update publicly any forward looking statements.
This discussion is permitted by the Private Securities Litigation Reform Act of
1995.